Skip to main content
. 2023 Mar 2;9:32. doi: 10.1038/s41531-023-00477-1

Fig. 5. Fraction of Parkinson’s disease patients remaining dementia free in the IBM MarketScan Research Databases.

Fig. 5

Kaplan–Meier plot of 754 matched pairs of men aged 40 or older diagnosed with Parkinson’s disease (PD) and newly started on terazosin, alfuzosin, or doxazosin (TZ/DZ/AZ; green) or tamsulosin (red). The red and green lines denote cumulative incidence of PD patients remaining dementia free, and the shaded areas denote 95% CI.